Merck (MRK) Tops Q3 EPS by 23c; narrows forecast
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $128.66 +2.56%
Revenue Growth %: +3.5%
Financial Fact:
Research and development: 5.14B
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: +3.5%
Financial Fact:
Research and development: 5.14B
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Merck (NYSE: MRK) reported Q3 EPS of $2.58, $0.23 better than the analyst estimate of $2.35. Revenue for the quarter came in at $17.28 billion versus the consensus estimate of $16.98 billion.
GUIDANCE:
Merck sees FY2025 EPS of $8.93-$8.98, versus the consensus of $8.89. Merck sees FY2025 revenue of $64.5-65 billion, versus the consensus of $64.81 billion.
For earnings history and earnings-related data on Merck (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gulfport Energy and Mobility Global to join S&P SmallCap 600
- GameStop 'remains focused on advancing' proposed eBay deal, offers adjusted EBITDA guidance - Filing
- Uranium Royalty Corp. sets shareholder vote on $1.14B Sweetwater deal
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
